Search results
Raja Sékaran
The National Law Review· 4 days agoRaja Sekaran Healthcare Lawyer counsels on governance issues, regulatory compliance, government investigations and white-collar defense, Medicare and Medicaid.
Dali owner lobbies up
Politico· 5 days ago...Transportation and Energy and Commerce committees. — Advocates will lobby for legislation aimed at expediting medical and other critical supplies throughout the nation’s transportation system during declared emergencies, as well as for the reauthorization of the Pandemic...Goldman Sachs’ 10,000...
Scientists develop new CRISPR gene editing platform for precision medicine and cancer treatment
Medical Xpress· 4 days agoCRISPR/Cas9 is a unique technology that enables geneticists and medical researchers to edit parts of the genome by removing, adding or altering sections of the DNA sequence ...
Drake-Kendrick Lamar Feud Timeline: Drake Deletes Diss Track References From Instagram
Forbes· 5 days agoJune 5Fans on Wednesday noticed all of Drake's posts on Instagram referencing the beef, including...
Erdogan turns up the heat on Israel as his party’s popularity wanes
CNN via Yahoo News· 6 days agoSome Western critics might accuse Erdogan of going too far in supporting Hamas, but recent events...
Winnebago County Public Health releases annual fatal overdose report
WBAY Green Bay· 5 days agoWinnebago County’s Overdose Fatality Review (OFR) team has released its 2023-24 report on overdose...
Winnebago County reports record-high 47 overdose deaths in 2023
FOX 11 Green Bay· 6 days agoWINNEBAGO COUNTY (WLUK) -- 47 overdose deaths occurred in Winnebago County last year, according to...
Head to Head Contrast: Fidelis Insurance (NYSE:FIHL) versus Allstate (NYSE:ALL)
ETF DAILY NEWS· 21 hours agoFidelis Insurance (NYSE:FIHL – Get Free Report) and Allstate (NYSE:ALL – Get Free Report) are both finance companies, but which is the better business? We will compare the two businesses based ...
AbbVie Advances Oncology Pipeline With Start of Multiple Myeloma Phase 3 Clinical Trial for...
Morningstar· 6 days agoABBV-383 is a B-cell maturation antigen (BCMA) bispecific antibody T-cell engager being evaluated in relapsed/refractory multiple myeloma (r/r MM)The CERVINO Phase 3 trial will evaluate the efficacy, safety, and tolerability of ABBV-383 monotherapy
Richmond activist with Gaza ties discusses life as full-time student, protest organizer
Richmond Times-Dispatch· 3 days ago“That is Palestinian reality,” Haddad said. Since October, Haddad has been at the forefront of that...
